Skip to main content Back to Top
Advertisement

12/9/2019

Polyvinyl Alcohol (Artificial Tears) Ophthalmic Solution

Products Affected - Description

    • Artificial Tears ophthalmic solution, Rugby Laboratories, 1.4%, 15 mL bottle, 1 count, NDC 00536-1084-94
    • Artificial Tears Solution ophthalmic solution, Akorn, 1.4%, 15 mL bottle, 1 count, NDC 17478-0060-12
    • Liquitears ophthalmic solution, Major, 1.4%, 15 mL bottle, 1 count, NDC 00904-6492-35
    • Tears Again ophthalmic solution, OCuSOFT, 1.4%, 15 mL bottle, 1 count, NDC 54799-0904-15
    • Tears Again ophthalmic solution, OCuSOFT, 1.4%, 30 mL bottle, 1 count, NDC 54799-0904-30

Reason for the Shortage

    • Akorn did not provide a reason for the shortage.
    • Altaire is not currently marketing polyvinyl alcohol 1.4% ophthalmic solution.
    • Major has Liquitears on shortage because they are updating the NDC number.
    • Ocusoft has Tears again on shortage because the product was recalled.
    • Rugby has Artificial Tears solution on shortage because they are updating the NDC number.

Available Products

    • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • Akorn has Artificial Tears Solution ophthalmic drops on allocation.
    • Major has Liquitears ophthalmic drops temporarily discontinued and the company cannot estimate a release date.
    • Rugby has Artificial Tears solution temporarily discontinued and the company cannot estimate a release date.
    • Ocusoft has Tears Again solution on back order and the company cannot estimate a release date.

Updated

Updated December 9, 2019 by Megan Dryer, PharmD. Created August 9, 2018 by Leslie Jensen, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins